Northern Sweden Health and Disease Study
NCT03426488 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120000
Last updated 2018-02-08
Summary
NSHDS (Northern Sweden Health and Disease Study) is an umbrella term for a prospective biobank with related survey data. The sample collection consists of three subcohorts, Västerbotten Intervention Programme (VIP), Mammography Screening Project (MA) and MONICA (MONItoring of Trends and Determinants in CArdiovascular Disease). The blood samples are stored at the Northern Sweden Biobank.
Conditions
- Cardiovascular Diseases
- Cancer
- Neurodegenerative Diseases
- Respiratory Disease
- Infection
Interventions
- BEHAVIORAL
-
VIP - Västerbotten Intervention Programme
Intervention on CVD (cardiovascular disease) and diabetes
Sponsors & Collaborators
-
Umeå University
lead OTHER
Principal Investigators
-
Göran Hallmans, MD PhD · Umeå University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1986-01-31
- Primary Completion
- 2026-01-31
- Completion
- 2026-01-31
Countries
- Sweden
Study Locations
More Related Trials
-
COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring
NCT04844632 ·Status: UNKNOWN
-
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
NCT04546841 ·Status: COMPLETED ·Phase: PHASE1
-
Fourth BNT162b2 COVID-19 Vaccine Dose
NCT05231005 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity
NCT05076227 ·Status: COMPLETED
-
Immune Response to Vaccination Against Covid-19, a Follow up Study
NCT04920357 ·Status: UNKNOWN
-
Bridging Study for Killed Oral Cholera Vaccine in Ethiopia
NCT01524640 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays
NCT01099488 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Human Immune Response to the JYNNEOS Vaccine
NCT06366672 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Effectiveness Study of Gardasil on Condyloma
NCT01553994 ·Status: COMPLETED
-
A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults
NCT05037097 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers
NCT05069623 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT
NCT05745987 ·Status: RECRUITING ·Phase: PHASE4
-
Fourth COVID-19 Vaccine Dose- mRNA1273
NCT05230953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety Study of NBP608 in Healthy Adult Volunteers
NCT03121638 ·Status: COMPLETED ·Phase: PHASE1
-
Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric Institutions
NCT04961502 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating the Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500
NCT00518492 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years
NCT04895982 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Responses to Smallpox Vaccination
NCT00325975 ·Status: COMPLETED
-
Immunisation for Adolescents Against Serious Communicable Diseases (B Part of it NT)
NCT04398849 ·Status: UNKNOWN
-
Comparative Evaluation of Covid-19 Vaccines Response
NCT04895007 ·Status: UNKNOWN
-
COVID-19 Vaccination of Immunodeficient Persons (COVAXID)
NCT04780659 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults
NCT02094586 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine
NCT05685953 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among Immunocompromised Adults
NCT05366322 ·Status: COMPLETED
-
Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults
NCT04818281 ·Status: COMPLETED ·Phase: PHASE1